Influencing Factors of Helicobacter Pylori Infection and Eradication Failure (NCT05226819) | Clinical Trial Compass
UnknownNot Applicable
Influencing Factors of Helicobacter Pylori Infection and Eradication Failure
China300 participantsStarted 2022-02-06
Plain-language summary
Helicobacter pylori (H. pylori) is closely related to the occurrence of gastric cancer and other diseases, the discovery and eradication of H. pylori infection has great significance to the prevention and treatment of related diseases. At the same time,understanding the influencing factors of H. pylori infection and eradication failure in the population can provide a scientific basis for the formulation of local H. pylori prevention and control strategies. So, the investigators intend to analyze the factors related to H. pylori infection and eradication failure in the outpatients of gastroenterology clinics in Xi'an, China.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Perform 13-UBT,
✓. Be able to understand the content of the questionnaire and answer the questions accurately,
✓. Permanent residents of Xi'an area,
✓. No previous HP eradication treatment,
✓. Agree to join the group and sign the informed consent form,
✓. Aged between 18-70.
Exclusion criteria
✕. Complicated with serious cardiovascular, respiratory, blood, liver, kidney, nerve or endocrine system diseases,
✕. Mental disease,
✕. Gastric or esophageal surgery history,
✕. Severe atypical hyperplasia of gastric epithelium, gastric malignant tumor or other malignant diseases
✕. Pregnant or lactating women,
What they're measuring
1
Infection rate
Timeframe: 1 year
2
The Affecting factors of Helicobacter pylori infection is investigated by questionnaire statistics.
Timeframe: 1 year
3
Eradication rate
Timeframe: 1 year
4
The Affecting factors of Helicobacter pylori eradication failure is investigated by questionnaire statistics.
Timeframe: 1 year
Trial details
NCT IDNCT05226819
SponsorSecond Affiliated Hospital of Xi'an Jiaotong University